Candidate gene expression analysis of toxin-induced dilated cardiomyopathy in the Turkey (Meleagris gallopavo)

Poultry Science

Volumn 85, Issue 12, 2006, Pages 2216-2221

  Lin, K C ^a   Gyenai, K ^a   Pyle, R L ^a   Geng, T ^a   Xu, J ^a   Smith, E J ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Cardiac troponin T; Cardiomyopathy; Phospholamban; Reverse transcription polymerase chain reaction; Turkey

Indexed keywords

AVES; MELEAGRIS GALLOPAVO; VERTEBRATA;

EID: 33846099986     PISSN: 00325791     EISSN: 15253171     Source Type: Journal    
DOI: 10.1093/ps/85.12.2216     Document Type: Article

References (29)

1. Ali, B. H. 1989. Pharmacology and toxicity of furazolidone in man and animals: Some recent research. Gen. Pharmacol. 20:557-563.
2. Biesiadecki, B. J., and J. P. Jin. 2002. Exon skipping in cardiac troponin T of turkeys with inherited dilated cardiomyopathy. J. Biol. Chem. 277:18459-18468.
3. Biesiadecki, B. J., K. L. Schneider, Z. Yu, S. M. Chong, and J. Jin. 2004. An R111c polymorphism in wild turkey cardiac troponin I accompanying the dilated cardiomyopathy-related abnormal splicing variant of cardiac troponin T with potentially compensatory effects. J. Biol. Chem. 279:13825-13832.
4. Czarnecki, C. M., E. F. Jankus, and B. D. Hultgren. 1973. Effects of furazolidone on the development of cardiomyopathies in turkey poults. Avian Dis. 18:125-133.
5. Dash, R., V. Kadambi, A. G. Schmidt, N. M. Tepe, D. Biniakiewicz, M. J. Gerst, A. M. Canning, W. T. Abraham, B. D. Hoit, S. B. Liggett, J. N. Lorenz, G. W. Dorn, and E. G. Kranias. 2001. Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality. Circulation 103:889-896.
6. Durand, J. B. 1999. Genetic basis of dilated cardiomyopathy. Curr. Opin. Cardiol. 14:225-233.
7. Fatkin, D., and R. M. Graham. 2002. Molecular mechanisms of inherited cardiomyopathies. Physiol. Rev. 82:945-980.
8. Frame, D. D., R. E. Buckner, and G. L. Anderson. 1999. Causes and control of spontaneous cardiomyopathy or roundheart disease in Utah turkeys. http://extension.usu.edu/files/publications/publication/AG_506.pdf Accessed Mar. 2006.
9. Genao, A., K. Seth, U. Schmidt, M. Carles, and J. K. Gwathmey. 1996. Dilated cardiomyopathy in turkeys: An animal model for the study of human heart failure. Lab. Anim. Sci. 46:399-404.
10. Grzeskowiak, R., H. Witt, M. Drungowski, R. Thermann, S. Hennig, A. Perrot, K. J. Osterziel, D. Klingbiel, S. Scheid, and R. Spang. 2003. Expression profiling of human idiopathic dilated cardiomyopathy. Cardiovasc. Res. 59:400-411.
11. Gyenai, K. B. 2005. Genetic analysis of toxin-induced dilated cardiomyopathy in the turkey (Meleagris gallopavo). MS Thesis. Virginia Tech, Blacksburg.
12. Hajjar, R. J., R. Liao, J. B. Young, F. Fuleihan, M. G. Glass, and J. K. Gwathmey. 1993. Pathophysiological and biochemical characterization of an avian model of dilated cardiomyopathy: Comparison to findings in human dilated cardiomyopathy. Cardiovasc. Res. 27:2212-2221.
13. Koss, K. L., and E. G. Kranias. 1996. Phospholamban: A prominent regulator of myocardial contractility. Circ. Res. 79:1059-1063.
14. Liew, C., and V. J. Dazu. 2004. Molecular genetics and genomics of heart failure. Nature 5:811-825.
15. CT Method. Methods 25:402-408.
16. McTiernan, C. F., C. S. Frye, B. H. Lemster, E. A. Kinder, M. L. Ogletree-Hughes, C. S. Moravec, and A. M. Feldman. 1999. The human phospholamban gene: Structure and expression. J. Mol. Cell. Cardiol. 31:679-692.
17. Paxton, C. N., M. E. Pierpont, and D. L. Kooyman. 2005. Identification of AFLP markers associated with round heart syndrome in turkeys. Int. J. Poult. Sci. 4:133-137.
18. Poller, W., U. Kuhl, C. Tschoepe, and M. Pauschinger. 2005. Genome-environment interactions in the molecular pathogenesis of dilated cardiomyopathy. J. Mol. Med. 83:579-586.
19. Rozen, S., and H. J. Skaletsky. 1997. Primer3. Code available at http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi Accessed Feb. 2005.
20. SAS Institute. 2002-2003. SAS software. Version 9.1. SAS Institute, Inc., Cary, NC.
21. Schmitt, J. P., M. Kamisago, M. Asahi, G. H. Li, F. Ahmad, U. Mende, E. G. Kranias, D. H. MacLennan, J. G. Seidman, and C. E. Seidman. 2003. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 299:1410-1413.
22. Schwinger, R. H. G., M. Bohm, U. Schmidt, P. Karczewski, U. Bavendiek, M. Flesch, E. Krause, and E. Erdmann. 1995. Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca2+-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with non-failing hearts. Circulation 92:3220-3228.
23. Smith, E. J., T. Geng, E. Long, F. W. Pierson, D. P. Sponenberg, C. Larson, and R. Gogal. 2005. Molecular analysis of the relatedness of five domesticated turkey strains. Biochem. Genet. 43:35-48.
24. Stabej, P., P. A. Leegwater, A. A. Stokhof, A. Domanjko-Petric, and B. A. van Oost. 2005. Evaluation of the phospholamban gene in purebred large-breed dogs with dilated cardiomyopathy. Am. J. Vet. Res. 66:432-436.
25. Toyofuku, T., and R. Zak. 1991. Characterization of cDNA and genomic sequences encoding a chicken phospholamban. J. Biol. Chem. 266:5375-5383.
26. Venkatraman, G., A. V. Gomes, W. G. L. Kerrick, and J. D. Potter. 2005. Characterization of troponin T dilated cardiomyopathy mutations in the fetal troponin isoform. J. Biol. Chem. 280:17584-17592.
27. White, A. H. 1989. Absorption, distribution, metabolism, and excretion of Furazolidone. Scand. J. Gastroenterol. 169:4-10.
28. Wu, D., J. Lin, Y. Chiu, C. Cheng, C. Shyu, K. Ueng, and C. Huang. 2003. Pathological and biochemical analysis of dilated cardiomyopathy of broiler chickens - An animal model. Chin. J. Physiol. 46:19-26.
29. Zepeda, E. A., and D. L. Kooyman. 2002. Breeding trial based on RAPD analysis of turkey spontaneous cardiomyopathy. Plant, Anim., Microbe Genomes X Conf., San Diego, CA. Scherago Int. Inc., Jersey City, NJ.